Receiver operator characteristic (ROC) curves analysis revealed that THBS2 was a comparable biomarker as Cyfra21-1 to distinguish early stage NSCLC or SC from healthy control subjects. This evidence concerns the gene THBS2 and non-small cell lung carcinoma.